Indications
The treatment of Dupuytren’s contracture in adult patients with a palpable cord. The treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.
Composition
- Active substance
- collagenase Clostridium histolyticum
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Xiapex
- Active substance
- collagenase Clostridium histolyticum
- ATC code
- M09AB02
- Therapeutic area
- Dupuytren Contracture
- Marketing authorisation holder
- Swedish Orphan Biovitrum AB
- Status